Nasdaq · CIK 0001098972
AGEN AGENUS INC
Insider trading from SEC Form 4. Last filing 13 d ago. Close $6.95 on Oct 13, 2026, +151% from the 52-week low and -30% from the high.
In brief
AGENUS INC (AGEN) has 148 SEC Form 4 filings on file from 10 insiders, the latest filed on Oct 2, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at AGEN. The newest: Garo H Armen (See Remarks) bought $324k of stock on Feb 15, 2024, filed Feb 15, 2024, scored 47 (moderate).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at AGENUS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Garo H Armen See Remarks buy | $324k 500,000 shares | +397% | +16% from low-70% from high | |
| 29Weak | Ulf Wiinberg director buy | $19k 25,000 shares | +25% | +17% from low-77% from high |
Transactions
The newest 50 of 163 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Thomas L Harrison director | AGrant or award Common Stock | +4,443 | $6.89 | $31k | 51,988 | 13 d ago |
| Oct 1, 2026 | Timothy Wright director | AGrant or award Deferred Stock Unitsderivative | +1,179 | - | - | 29,808 | 13 d ago |
| Aug 5, 2026 | Marco Tullio Marcucci director | AGrant or award Stock Optionderivative | +7,500 | $0.00 | $0 | 7,500 | 29 d ago |
| Aug 10, 2026 | Garo H Armen See Remarks | AGrant or award Stock Optionderivative | +1,971,500 | $0.00 | $0 | 1,971,500 | Aug 12, 2026 |
| Aug 5, 2026 | Brian Corvese director | AGrant or award Stock Optionderivative | +100,000 | $0.00 | $0 | 100,000 | Aug 11, 2026 |
| Aug 5, 2026 | Thomas L Harrison director | AGrant or award Stock Optionderivative | +50,000 | $0.00 | $0 | 50,000 | Aug 11, 2026 |
| Aug 5, 2026 | Timothy Wright director | AGrant or award Stock Optionderivative | +50,000 | $0.00 | $0 | 50,000 | Aug 7, 2026 |
| Aug 5, 2026 | Jennifer Buell See Remarks | AGrant or award Stock Optionderivative | +200,000 | $0.00 | $0 | 200,000 | Aug 7, 2026 |
| Aug 5, 2026 | Susan B Hirsch director | AGrant or award Stock Optionderivative | +50,000 | $0.00 | $0 | 50,000 | Aug 7, 2026 |
| Aug 5, 2026 | Steven J O'Day Chief Medical Officer | AGrant or award Stock Optionderivative | +100,000 | $0.00 | $0 | 100,000 | Aug 7, 2026 |
| Jul 10, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,852 | $3.35 | $16k | 371,108 | Jul 14, 2026 |
| Jul 1, 2026 | Timothy Wright director | AGrant or award Deferred Stock Unitsderivative | +2,268 | - | - | 26,181 | Jul 7, 2026 |
| Jul 1, 2026 | Thomas L Harrison director | AGrant or award Common Stock | +8,547 | $3.58 | $31k | 47,545 | Jul 7, 2026 |
| Jun 26, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +5,364 | $3.03 | $16k | 366,256 | Jun 30, 2026 |
| Jun 12, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,925 | $3.30 | $16k | 360,892 | Jun 16, 2026 |
| May 29, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,644 | $3.50 | $16k | 355,967 | Jun 2, 2026 |
| May 15, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,540 | $3.58 | $16k | 351,323 | May 19, 2026 |
| May 1, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,233 | $3.84 | $16k | 346,783 | May 5, 2026 |
| Apr 24, 2026 | Brian Corvese director | AGrant or award Stock Optionderivative | +210,000 | $0.00 | $0 | 210,000 | Apr 28, 2026 |
| Apr 24, 2026 | Garo H Armen See Remarks | AGrant or award Stock Optionderivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Apr 28, 2026 |
| Apr 24, 2026 | Austin Charette Principal Accounting Officer | AGrant or award Stock Optionderivative | +5,000 | $0.00 | $0 | 5,000 | Apr 28, 2026 |
| Apr 24, 2026 | Timothy Wright director | AGrant or award Stock Optionderivative | +105,000 | $0.00 | $0 | 105,000 | Apr 28, 2026 |
| Apr 24, 2026 | Thomas L Harrison director | AGrant or award Stock Optionderivative | +122,500 | $0.00 | $0 | 122,500 | Apr 28, 2026 |
| Apr 24, 2026 | Steven J O'Day Chief Medical Officer | AGrant or award Stock Optionderivative | +70,000 | $0.00 | $0 | 70,000 | Apr 28, 2026 |
| Apr 24, 2026 | Jennifer Buell See Remarks | AGrant or award Stock Optionderivative | +300,000 | $0.00 | $0 | 300,000 | Apr 28, 2026 |
| Apr 24, 2026 | Susan B Hirsch director | AGrant or award Stock Optionderivative | +105,000 | $0.00 | $0 | 105,000 | Apr 28, 2026 |
| Apr 24, 2026 | Garo H Armen See Remarks | AGrant or award Stock Optionderivative | +27,750 | $0.00 | $0 | 27,750 | Apr 28, 2026 |
| Apr 24, 2026 | Austin Charette Principal Accounting Officer | AGrant or award Stock Optionderivative | +17,619 | $0.00 | $0 | 17,619 | Apr 28, 2026 |
| Apr 24, 2026 | Steven J O'Day Chief Medical Officer | AGrant or award Stock Optionderivative | +95,333 | $0.00 | $0 | 95,333 | Apr 28, 2026 |
| Apr 24, 2026 | Jennifer Buell See Remarks | AGrant or award Stock Optionderivative | +5,000 | $0.00 | $0 | 5,000 | Apr 28, 2026 |
| Apr 24, 2026 | Garo H Armen See Remarks | AGrant or award Stock Optionderivative | +137,550 | $0.00 | $0 | 137,550 | Apr 28, 2026 |
| Apr 17, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +3,403 | $4.79 | $16k | 342,550 | Apr 21, 2026 |
| Apr 1, 2026 | Thomas L Harrison director | AGrant or award Common Stock | +9,228 | $3.32 | $31k | 38,998 | Apr 13, 2026 |
| Apr 3, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,629 | $3.33 | $15k | 339,147 | Apr 6, 2026 |
| Apr 1, 2026 | Timothy Wright director | AGrant or award Deferred Stock Unitsderivative | +2,448 | - | - | 26,361 | Apr 2, 2026 |
| Mar 20, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +3,983 | $3.71 | $15k | 334,518 | Mar 24, 2026 |
| Mar 6, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,994 | $2.96 | $15k | 330,535 | Mar 9, 2026 |
| Feb 20, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,829 | $3.06 | $15k | 325,541 | Feb 24, 2026 |
| Feb 6, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +5,027 | $2.94 | $15k | 320,712 | Feb 9, 2026 |
| Jan 23, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,562 | $3.24 | $15k | 315,685 | Jan 26, 2026 |
| Jan 9, 2026 | Garo H Armen See Remarks | AGrant or award Common Stock | +3,780 | $3.91 | $15k | 311,123 | Jan 12, 2026 |
| Jan 2, 2026 | Timothy Wright director | AGrant or award Deferred Stock Unitsderivative | +2,041 | - | - | 23,913 | Jan 5, 2026 |
| Jan 2, 2026 | Thomas L Harrison director | AGrant or award Common Stock | +7,691 | $3.98 | $31k | 29,770 | Jan 5, 2026 |
| Dec 26, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,942 | $3.31 | $16k | 307,343 | Dec 29, 2025 |
| Dec 12, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,316 | $3.79 | $16k | 302,401 | Dec 15, 2025 |
| Nov 28, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +3,587 | $4.56 | $16k | 298,085 | Dec 1, 2025 |
| Nov 14, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +3,769 | $4.34 | $16k | 294,498 | Nov 17, 2025 |
| Oct 31, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,120 | $3.97 | $16k | 290,729 | Nov 5, 2025 |
| Oct 17, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +4,216 | $3.88 | $16k | 286,609 | Oct 21, 2025 |
| Oct 3, 2025 | Garo H Armen See Remarks | AGrant or award Common Stock | +3,951 | $4.14 | $16k | 282,393 | Oct 6, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Garo H ArmenSee Remarks
- Jennifer BuellSee Remarks
- Austin CharettePrincipal Accounting Officer
- Brian Corvesedirector
- Thomas L Harrisondirector
- Susan B Hirschdirector
- Marco Tullio Marcuccidirector
- Steven J O'DayChief Medical Officer
- Ulf Wiinbergdirector
- Timothy Wrightdirector
Questions about AGEN
Answered from the filings on this page, as of the latest one.
Are insiders buying AGEN?
No. In the last 90 days no insider at AGENUS INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AGEN on the open market?
Garo H Armen (See Remarks) bought $324k of AGEN on Feb 15, 2024 and filed the Form 4 on Feb 15, 2024. InsiderTell scored 47 (moderate).
How many insiders file Form 4 at AGENUS INC?
10 people have filed a Form 4 at AGENUS INC, among them Garo H Armen (See Remarks), Jennifer Buell (See Remarks), Austin Charette (Principal Accounting Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.